Do the Large Benefits Justify the Large Costs of Adjuvant Breast Cancer Trastuzumab?
Year: 2007
Type: editorial
Source: Journal of Clinical Oncology
Authors: Bruce E. Hillner, Thomas J. Smith
Language: English
Subfield: Economics and Econometrics
Domain: Social Sciences
Open Access status: closed
OpenAlex ID: W2167727926
